From the clinical point of view, there are also several biomarkers such as C reactive protein (CRP), erythrocyte sedimentation rate (ESR), platelets, and fecal calprotectin that can be used for objective evaluation of disease activity and inflammation in IBD patients [69]. This evidence concerns the gene CRP and inflammatory bowel disease.